CLSA Analysts Have Initiated Coverage On Coronado Global Resources

coronado global

With a sell recommendation and $2.40 price target, citing stretched valuations, a coverage on Coronado Global Resources has been initiated by CLSA analysts. Opportunistically exiting less than seven months after buying its key asset, the company is wary of the private equity owners, while coal prices run at multi-year highs. In a research note to clients on Wednesday, CLSA analyst Dylan Kelly wrote.

The assets are complex and lower margin structurally, the company can see little reason for investors to be here with a far more attractive coal business such as Whitehaven Coal, while they can understand the allure of the dividend policy. After Coronado raised $774 million, well below its upper target of $1.39 billion, CHESS depositary on the ASX on Tuesday, representing 0.1 shares in the US registered coking coal miner began trading. The offer was priced at $4 a share, after an auction for fund managers last week, at the bottom end of its $4 to $4.80 targeted range. [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

On Tuesday the share closed 10 percent below the issue price, at $3.60. Coronado’s business is structurally lower-margin at 25 percent, as per Kelly, due to a combination of low-value product mix, peculiar onerous legacy royalties/contracts and low coal quality, which is roughly half its peers. By way of price-linked costs, a lot of the price upside appears to have been captured. In the 2019 financial year, Kelly expects the business to generate a 10 per cent free cash flow yield and says this is “compelling” considering its dividend payout policy of 100 percent in FY19, dropping to 60 per cent to 100 per cent in FY20.

Revised reserve and mine life for Curragh are the next catalysts for Coronado, but for investors there seem to be a little reason in the name. The total revenues were up to $799,683 on six months ended June 30, 2018 from $396,151 in June 30, 2017. The EBITDA was also marginally up from $133,412 in June 30, 2017 to $134,980 for six months ended June 30, 2018. However, the net income decreased from at total of $90,917 in 2017 to $35,651 in 2018.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report